Lima Corporate was awarded three new Orthopaedic Data Evaluation Panel ratings for hip implants in the U.K. The ratings are intended to indicate that a device’s clinical performance falls in line with National Institute for Health and Care Excellence guidelines for implant survivorship.
AxioMed modified terms of a previously-signed 15-year exclusive license agreement with DSM Biomedical, holder of the patent on polymer technology used in AxioMed’s viscoelastic disc replacement.
Carevature commenced limited U.S. launch of Dreal™ products for spinal decompression. Full launch is slated for 2017. The system is also available for sale in the EU.
CartiHeal received FDA approval of its Investigational Device Exemption application submitted for the Agili-C™ implant, in support of a Premarket Approval application.
Anika Therapeutics received CE Mark approval for ORTHOVISC®-T injection indicated to relieve pain and restore function in tendons affected by chronic lateral epicondylosis.
Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products.